6.
Johnson P, Pinato D, Kalyuzhnyy A, Toyoda H
. Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma. J Clin Oncol. 2022; 40(19):2078-2082.
DOI: 10.1200/JCO.21.02373.
View
7.
Ananchuensook P, Sriphoosanaphan S, Suksawatamnauy S, Siripon N, Pinjaroen N, Geratikornsupuk N
. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization. BMC Gastroenterol. 2022; 22(1):295.
PMC: 9199248.
DOI: 10.1186/s12876-022-02366-y.
View
8.
Saloojee A, Skinner D, Loots E, Hardcastle T, Muckart D
. Hepatic dysfunction: A common occurrence in severely injured patients. Injury. 2016; 48(1):127-132.
DOI: 10.1016/j.injury.2016.08.017.
View
9.
Liu P, Hsu C, Hsia C, Lee Y, Chiou Y, Huang Y
. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era. J Gastroenterol Hepatol. 2016; 32(4):879-886.
DOI: 10.1111/jgh.13608.
View
10.
Shi L, Zhang D, Zhang J
. Albumin-bilirubin score is associated with in-hospital mortality in critically ill patients with acute pancreatitis. Eur J Gastroenterol Hepatol. 2020; 32(8):963-970.
DOI: 10.1097/MEG.0000000000001753.
View
11.
Chou S, Rau C, Su W, Tsai C, Hsu S, Hsieh C
. The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries. Risk Manag Healthc Policy. 2023; 16:279-286.
PMC: 9975765.
DOI: 10.2147/RMHP.S397210.
View
12.
Ge P, Du S, Mao Y
. Advances in preoperative assessment of liver function. Hepatobiliary Pancreat Dis Int. 2014; 13(4):361-70.
DOI: 10.1016/s1499-3872(14)60267-8.
View
13.
Wang Z, Fan Q, Wang M, Wang E, Li H, Liu L
. Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma. Ann Transl Med. 2020; 8(8):537.
PMC: 7214881.
DOI: 10.21037/atm.2020.02.114.
View
14.
Ho S, Liu P, Hsu C, Huang Y, Liao J, Su C
. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade. Expert Rev Gastroenterol Hepatol. 2022; 16(9):903-911.
DOI: 10.1080/17474124.2022.2117156.
View
15.
Shimose S, Iwamoto H, Tanaka M, Niizeki T, Kajiwara M, Itano S
. Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers (Basel). 2022; 14(17).
PMC: 9454839.
DOI: 10.3390/cancers14174284.
View
16.
Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marin-Ciancas F, Malafarina V
. Serum albumin and health in older people: Review and meta analysis. Maturitas. 2015; 81(1):17-27.
DOI: 10.1016/j.maturitas.2015.02.009.
View
17.
Porte R, Lisman T, Tripodi A, Caldwell S, Trotter J
. The International Normalized Ratio (INR) in the MELD score: problems and solutions. Am J Transplant. 2010; 10(6):1349-53.
DOI: 10.1111/j.1600-6143.2010.03064.x.
View
18.
Tsilimigras D, Hyer J, Moris D, Sahara K, Bagante F, Guglielmi A
. Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients. J Surg Oncol. 2019; 120(2):206-213.
DOI: 10.1002/jso.25486.
View
19.
Hsieh C, Chen Y, Hsu S, Hsieh H, Chien P
. Defining polytrauma by abbreviated injury scale ≥ 3 for a least two body regions is insufficient in terms of short-term outcome: A cross-sectional study at a level I trauma center. Biomed J. 2018; 41(5):321-327.
PMC: 6306305.
DOI: 10.1016/j.bj.2018.08.007.
View
20.
Ho S, Yuan M, Liu P, Hsu C, Huang Y, Liao J
. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade. Scand J Gastroenterol. 2022; 58(1):61-69.
DOI: 10.1080/00365521.2022.2098052.
View